(PharmaNewsWire.Com, March 23, 2017 ) Over the years, majority of the minimally invasive cardiovascular surgeries have been increasingly using atherectomy and thrombectomy devices to increase the success rate of surgeries and reduce the procedure and recovery time. Atherectomy devices are primarily used to clear blood vessels that have been occluded by fat accumulation (atherosclerosis plaque) . Thrombectomy devices, on the other hand, are used to extract, excise, or disrupt blood clots. They use a variety of methods to safely remove emboli in any part of the body. The global thrombectomy devices market is witnessing continuous technological developments and innovations.
Publisher's analysts forecast the global thrombectomy devices market to grow at a CAGR of 5.73% during the period 2016-2020. For more information about this report: http://www.reportsweb.com/global-thrombectomy-devices-market-2016-2020 . Covered in this report The report covers the present scenario and the growth prospects of the global thrombectomy devices market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of thrombectomy products provided by various vendors in the market. The market is divided into the following segments based on geography: - Americas - APAC - EMEA
Publisher's report, Global Thrombectomy Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: